Exploring the relationship between intestinal microbiota and immune checkpoint inhibitors in the treatment of non-small cell lung cancer: insights from the “lung and large intestine stand in exterior-interior relationship” theory
ObjectiveThis study is aim to discern the Traditional Chinese Medicine (TCM) syndrome classifications relevant to immunotherapy sensitive in non-small cell lung cancer (NSCLC) patients, and to delineate intestinal microbiota biomarkers and impact that wield influence over the efficacy of NSCLC immun...
Main Authors: | Luwei Li, Hongmei Zhong, Yajie Wang, Zongying Pan, Shumei Xu, Shuai Li, Guilin Zeng, Weiwei Zhang, Jie Li, Lang He |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2024.1341032/full |
Similar Items
-
Analysis of abnormal intestinal flora on risk of intestinal cancer and effect of heparin on formation of bacterial biofilm
by: Qilong Chen, et al.
Published: (2022-01-01) -
Research Progress on the Protective Effect of Intestinal Flora on
Radiation-induced Lung Injury in Thoracic Tumors
by: Guohui LIU, et al.
Published: (2023-06-01) -
Zengshengping improves lung cancer by regulating the intestinal barrier and intestinal microbiota
by: E. Sun, et al.
Published: (2023-03-01) -
A network meta-analysis to evaluate the efficacy of traditional Chinese medicine on intestinal flora in patients with gastrointestinal cancer
by: Niran Feng, et al.
Published: (2022-11-01) -
Bibliometric analysis of intestinal microbiota and lung diseases
by: Weiting Sun, et al.
Published: (2024-02-01)